Comprehensive analysis of single-cell and bulk RNA sequencing reveals postoperative progression markers for non-muscle invasive bladder cancer and predicts responses to immunotherapy
Abstract Background Non-muscle-invasive bladder cancer (NMIBC) is renowned for its high recurrence, invasiveness, and poor prognosis. Consequently, developing new biomarkers for risk assessment and investigating innovative therapeutic targets postoperative in NMIBC patients are crucial to aid in tre...
Saved in:
| Main Authors: | Zhiliang Xiao, Xin Liu, Yuan Wang, Sicong Jiang, Yan Feng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-11-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01548-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RNA-seq profiling identified a three-lncRNA panel in serum as potential biomarker for muscle-invasive bladder cancer
by: Xiumei Jiang, et al.
Published: (2024-12-01) -
Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer
by: Ekamjit S. Deol, et al.
Published: (2024-11-01) -
Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
by: Yongsoo Jo, et al.
Published: (2024-11-01) -
CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer
by: Xiaolin Lu, et al.
Published: (2024-11-01) -
Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
by: Mina Cho, et al.
Published: (2024-12-01)